| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 07/05/2011 | CA2471610C Cosmetic compositions comprising a cyclodipeptide compound |
| 07/05/2011 | CA2446136C Pyruvate derivatives |
| 06/30/2011 | WO2011077761A1 Acidic extracts and beverages containing 2,5-piperazinedione,3,6-bis(phenylmethyl)-,(3s,6s)- |
| 06/30/2011 | WO2011077759A1 Extracts and beverages containing 2, 5-piperazinedione, 3, 6-bis (phenylmethyl) -, (3s, 6s) - |
| 06/30/2011 | WO2011034659A3 Advantageous mu-opiate receptor peptide compounds |
| 06/30/2011 | US20110160127 Prodrugs of Neuraminidase Inhibitors |
| 06/30/2011 | CA2785410A1 Tyrosine bioconjugation through aqueous ene-like reactions |
| 06/29/2011 | EP2338899A1 Peptides for activation and inhibition of delta PKC |
| 06/29/2011 | EP2338522A1 Antitumoural therapies |
| 06/29/2011 | EP1730142B1 Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus |
| 06/29/2011 | CN102112486A Hepatitis c virus inhibitors |
| 06/29/2011 | CN101463074B Method for synthesizing cell toxic alkaloid and epimer thereof |
| 06/23/2011 | WO2011074731A1 Peptide having a blood pressure-lowering ability |
| 06/23/2011 | WO2011019839A3 Glycopeptide and lipoglycopeptide antibiotics with improved solubility |
| 06/23/2011 | US20110150910 Methods of inducing an immune response |
| 06/22/2011 | EP2336165A1 Peptides and compounds that bind to the thrombopoietin receptor |
| 06/22/2011 | EP2032595B1 Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application |
| 06/22/2011 | EP1797111B1 Acylsulfonamide compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 06/22/2011 | CN1739029B Prion protein ligands and methods of use |
| 06/22/2011 | CN102105553A Novel lipid dipeptide and gel |
| 06/22/2011 | CN102105485A Selective caspase inhibitors and uses thereof |
| 06/22/2011 | CN102101881A Preparation and application of pidotimod potassium salt |
| 06/21/2011 | US7964632 Methods of treatment using a prodrug of an excitatory amino acid |
| 06/21/2011 | US7964366 Methods and compositions for detection of Ehrlichia chaffeensis (VLPT) |
| 06/21/2011 | CA2355347C Pharmaceutical compositions comprising quinapril magnesium |
| 06/16/2011 | WO2011070573A1 Antimicrobial water treatment membranes and production thereof |
| 06/16/2011 | US20110144170 Fc RECEPTOR MODULATING COMPOUNDS AND COMPOSITIONS |
| 06/16/2011 | US20110144037 Substrates and Inhibitors of Antiplasmin Cleaving Enzyme and Fibroblast Activation Protein and Methods of Use |
| 06/16/2011 | US20110143991 Peptides for Activation and Inhibition of Delta-PKC |
| 06/16/2011 | US20110142989 Hydrolysed Casein Product Comprising Tripeptides IPP and/or VPP |
| 06/15/2011 | EP2333118A1 Method for rapid detection and identification of bioagents |
| 06/15/2011 | EP2332968A1 Stabilized alpha helical peptides derived from the BCL2-family for therapy. |
| 06/15/2011 | EP2332967A1 Stabilized alpha helical peptides derived from the BCL2-family for therapy. |
| 06/15/2011 | EP2332963A2 Process for preparing macrocyclic compounds |
| 06/15/2011 | EP2332962A1 Cyclopenta[g]quinazoline compounds for use in the treatment of inflammatory or allergic conditions |
| 06/15/2011 | EP2331561A1 Libraries of peptide conjugates and methods for making them |
| 06/15/2011 | EP2331560A1 Peptides useful in the treatment and/or care of skin, mucous membranes, scalp and/or hair and their use in cosmetic or pharmaceutical compositions |
| 06/15/2011 | EP2331559A1 Bioactive pre-tubulysins and use thereof |
| 06/15/2011 | EP2331553A1 Hepatitis c virus inhibitors |
| 06/15/2011 | EP2331517A1 Bioluminescent assays using cyanobenzothiazole compounds |
| 06/15/2011 | EP2331514A2 Cyclic polyamines for binding phosphatidylserine |
| 06/15/2011 | EP2331048A1 Oligomeric biosurfactants in dermatocosmetic compositions |
| 06/15/2011 | EP2104535B9 Compounds and compositions as channel activating protease inhibitors |
| 06/15/2011 | EP1455809B1 Inhibitors of hepatitis c virus |
| 06/15/2011 | CN102098923A Lactobacillus helveticus strains for producing hypotensive peptides |
| 06/15/2011 | CN102093470A Liquid phase synthesis method of Cyclo(His-Pro) (CHP) |
| 06/15/2011 | CN102093469A Milk-derived antioxidant active peptide and composition thereof |
| 06/15/2011 | CN102093468A Method for synthesizing reduced glutathione |
| 06/15/2011 | CN102093467A Dipeptide iron chelate for feed additives and preparation method thereof |
| 06/15/2011 | CN102093151A Method for synthesizing amide compounds |
| 06/14/2011 | US7960570 Small molecule inhibitors of rotamase enzyme activity |
| 06/14/2011 | US7960508 A peptide fragment containing selenocysteine has a lowered toxicity than selenocystine, exhibits a cytotoxicity-inhibitory activity; screening a drug having cytotoxicity-inhibitory activity by utilizing a cellular sudden death phenomenon in a cell culture system; glutathione peroxidase activity |
| 06/14/2011 | US7960506 Bis-sulfhydryl macrocyclization systems |
| 06/14/2011 | US7960398 Potent inhibitors of TNF activity |
| 06/09/2011 | US20110136726 Novel antimicrobial agents |
| 06/08/2011 | EP2330112A1 Collagen peptide, dipeptide, and agent for prevention of disease |
| 06/08/2011 | EP2328412A1 Iap inhibitors |
| 06/07/2011 | CA2548160C Process for purifying interferon beta |
| 06/07/2011 | CA2470515C Dna minor groove binding compounds |
| 06/07/2011 | CA2442194C Novel peptide sy |
| 06/07/2011 | CA2423190C Angiogenic agents and their uses |
| 06/03/2011 | WO2011066285A2 Peptide-based treatment for neurodegenerative diseases |
| 06/03/2011 | WO2011063475A1 Methods of preparing hydrogels by enzyme catalysis and subsequent inactivation |
| 06/02/2011 | US20110131671 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 06/02/2011 | US20110130349 Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and Conditions |
| 06/02/2011 | US20110129611 Decorating hydroxyapatite biomaterials with modular biologically active molecules |
| 06/02/2011 | US20110129482 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 06/02/2011 | US20110129444 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 06/01/2011 | EP2327986A1 Kokumi-imparting agent |
| 06/01/2011 | EP2327713A1 Metal-binding compounds and uses therefor |
| 06/01/2011 | EP2327712A2 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 06/01/2011 | CN102079771A Estrogen amino-acid ester compound with antitumor activity as well as synthetic method thereof |
| 05/31/2011 | US7951911 Carbon nanotube binding peptides |
| 05/31/2011 | US7951904 Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor |
| 05/31/2011 | US7951572 Construction of gold nanoparticle-based peptide chip, and assaying enzyme activity and inhibitor effect using secondary ion mass spectrometric analysis thereof |
| 05/31/2011 | US7951375 Methods of inducing an immune response |
| 05/31/2011 | US7951362 Compositions and methods of use of targeting peptides against placenta and adipose tissues |
| 05/31/2011 | CA2301942C Molecular mimetics of meningococcal b epitopes |
| 05/31/2011 | CA2231772C Advanced glycation end-product intermediaries and post-amadori inhibition |
| 05/31/2011 | CA2172282C Chiral surfactants and methods for their use in chiral separations |
| 05/26/2011 | WO2011061713A1 Method for the production of extracellular glutathione with high yields |
| 05/26/2011 | WO2011024079A3 Peptoid agonists of nerve growth factor and their use as medicaments |
| 05/26/2011 | US20110123496 Bismacrocyclic compounds as hepatitis c virus inhibitors |
| 05/26/2011 | US20110123452 Metal oligomers and polymers and their use in biology and medicine |
| 05/26/2011 | US20110123450 Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical application |
| 05/25/2011 | EP2139910B1 Method for the synthesis of peptides without solvent |
| 05/25/2011 | EP1972636B1 Cycloalkylcarbonylamino acid derivative and process for producing the same |
| 05/25/2011 | EP1934243B1 Ring-closing metathesis process for the preparation of macrocyclic peptides |
| 05/25/2011 | EP1697400B1 Biphenyl-substituted antibacterial macrocycles |
| 05/25/2011 | EP1478666B1 Dermopharmaceutically and cosmetically active oligopeptides |
| 05/25/2011 | CN102076706A A novel anti-aging skincare cream, the cosmetic device and cream within |
| 05/25/2011 | CN101560244B New method for synthesizing argatroban by combining solid phase method and liquid phase method |
| 05/24/2011 | US7947645 APO E analogs and methods for their use |
| 05/24/2011 | US7947267 Macular degeneration, choroidal or retinal neovascularization, or ocular inflammation; administering a poxvirus viral complement interfering protein (VCIP) |
| 05/24/2011 | CA2393710C Caspase inhibitors and uses thereof |
| 05/24/2011 | CA2303428C .alpha.-ketoamide multicatalytic protease inhibitors |
| 05/19/2011 | WO2011060229A1 Porous thin films |
| 05/19/2011 | WO2011058982A1 Therapeutic agent for gastrointestinal diseases |
| 05/19/2011 | WO2011057806A1 Tubulin inhibitors |
| 05/19/2011 | WO2011057805A1 Tubulin inhibitors |